BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11327838)

  • 1. Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p.
    Thual C; Bousset L; Komar AA; Walter S; Buchner J; Cullin C; Melki R
    Biochemistry; 2001 Feb; 40(6):1764-73. PubMed ID: 11327838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the prion Ure2p in protein fibrils assembled in vitro.
    Fay N; Redeker V; Savistchenko J; Dubois S; Bousset L; Melki R
    J Biol Chem; 2005 Nov; 280(44):37149-58. PubMed ID: 16131495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
    Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae.
    Bousset L; Belrhali H; Janin J; Melki R; Morera S
    Structure; 2001 Jan; 9(1):39-46. PubMed ID: 11342133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion domain initiation of amyloid formation in vitro from native Ure2p.
    Taylor KL; Cheng N; Williams RW; Steven AC; Wickner RB
    Science; 1999 Feb; 283(5406):1339-43. PubMed ID: 10037606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2.
    Thual C; Komar AA; Bousset L; Fernandez-Bellot E; Cullin C; Melki R
    J Biol Chem; 1999 May; 274(19):13666-74. PubMed ID: 10224139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen/deuterium exchange mass spectrometric analysis of conformational changes accompanying the assembly of the yeast prion Ure2p into protein fibrils.
    Redeker V; Halgand F; Le Caer JP; Bousset L; Laprévote O; Melki R
    J Mol Biol; 2007 Jun; 369(4):1113-25. PubMed ID: 17482207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and assembly properties of the N-terminal domain of the prion Ure2p in isolation and in its natural context.
    Bousset L; Bonnefoy J; Sourigues Y; Wien F; Melki R
    PLoS One; 2010 Mar; 5(3):e9760. PubMed ID: 20339590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide bond formation significantly accelerates the assembly of Ure2p fibrils because of the proximity of a potential amyloid stretch.
    Fei L; Perrett S
    J Biol Chem; 2009 Apr; 284(17):11134-41. PubMed ID: 19258323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folding of the yeast prion protein Ure2: kinetic evidence for folding and unfolding intermediates.
    Galani D; Fersht AR; Perrett S
    J Mol Biol; 2002 Jan; 315(2):213-27. PubMed ID: 11779240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
    Catharino S; Buchner J; Walter S
    Biol Chem; 2005 Jul; 386(7):633-41. PubMed ID: 16207084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equilibrium folding properties of the yeast prion protein determinant Ure2.
    Perrett S; Freeman SJ; Butler PJ; Fersht AR
    J Mol Biol; 1999 Jul; 290(1):331-45. PubMed ID: 10388576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells.
    Masison DC; Wickner RB
    Science; 1995 Oct; 270(5233):93-5. PubMed ID: 7569955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and assembly properties of the yeast prion Ure2p.
    Bousset L; Thual C; Belrhali H; Morera S; Melki R
    C R Biol; 2002 Jan; 325(1):3-8. PubMed ID: 11862619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction domains of Ure2p, a prion-like protein of yeast.
    Fernandez-Bellot E; Guillemet E; Baudin-Baillieu A; Gaumer S; Komar AA; Cullin C
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):403-7. PubMed ID: 10024516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.
    Wickner RB
    Science; 1994 Apr; 264(5158):566-9. PubMed ID: 7909170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of distinct [URE3] yeast prion strains.
    Schlumpberger M; Prusiner SB; Herskowitz I
    Mol Cell Biol; 2001 Oct; 21(20):7035-46. PubMed ID: 11564886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between stability of folding intermediates and amyloid formation for the yeast prion Ure2p: a quantitative analysis of the effects of pH and buffer system.
    Zhu L; Zhang XJ; Wang LY; Zhou JM; Perrett S
    J Mol Biol; 2003 Apr; 328(1):235-54. PubMed ID: 12684011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.
    Edskes HK; Gray VT; Wickner RB
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1498-503. PubMed ID: 9990052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.